Electromed, Inc. ELMD
AMEX · United States · Health Technology
$28.10-0.40 (-1.40%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
NEW PRAGUE, Minn., September 09, 2026--Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event
On August 25, Electromed (NASDAQ:ELMD) reported fiscal fourth-quarter results that extended a streak few small-cap medical device companies can claim: fifteen consecutive quarters of year-over-year revenue and profit growth. Net revenue hit a record $19.4 million, up 11.6% from a year earlier, and diluted earnings per share climbed to $0.39 from $0.25. Those headline numbers […]
Moby summary of Electromed, Inc.'s Q4 2026 earnings call
Electromed Inc (ELMD) delivers record Q4 revenue of $19.4 million, up 11.6% year-over-year, with full-year EPS reaching $1.30 per diluted share.
NEW PRAGUE, Minn., August 25, 2026--Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial Results
NEW PRAGUE, Minn., August 25, 2026--Electromed Announces CEO’s Planned Retirement
NEW PRAGUE, Minn., August 11, 2026--Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026
Senseonics (SENS) delivered earnings and revenue surprises of -14.55% and +10.73%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.